ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Novo Integrated Sciences Inc

Novo Integrated Sciences Inc (NVOS)

0.2932
0.0305
(11.61%)
마감 15 10월 5:00AM
0.2651
-0.0281
(-9.58%)
시간외 거래: 8:49AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.2651
매수가
0.2653
매도가
0.2799
거래량
328,181
0.263 일간 변동폭 0.2984
0.20 52주 범위 3.445
market_cap
전일 종가
0.2627
개장가
0.2659
최근 거래 시간
20
@
0.28
마지막 거래 시간
재정 규모
US$ 94,588
VWAP
0.288219
평균 볼륨(3m)
418,712
발행 주식
19,054,523
배당수익률
-
주가수익률
-0.42
주당순이익(EPS)
-0.69
매출
12.57M
순이익
-13.22M

Novo Integrated Sciences Inc 정보

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. It has two reportable segments: ... Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. It has two reportable segments: healthcare services and product manufacturing and development. 더 보기

섹터
Engines And Turbines
산업
Engines And Turbines
웹사이트
본부
Las Vegas, Nevada, USA
설립됨
-
Novo Integrated Sciences Inc is listed in the Engines And Turbines sector of the 나스닥 with ticker NVOS. The last closing price for Novo Integrated Sciences was US$0.26. Over the last year, Novo Integrated Sciences shares have traded in a share price range of US$ 0.20 to US$ 3.445.

Novo Integrated Sciences currently has 19,054,523 shares in issue. The market capitalisation of Novo Integrated Sciences is US$5.01 million. Novo Integrated Sciences has a price to earnings ratio (PE ratio) of -0.42.

NVOS 최신 뉴스

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of...

Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received notice of the commencement of disbursement for the complete monetization of a Standby...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.029112.33050847460.2360.29630.2362179290.26142335CS
4-0.0349-11.63333333330.30.33660.232249210.28074847CS
12-0.3299-55.44537815130.5950.71450.24187120.42002891CS
26-0.1999-42.98924731180.4651.40990.238329200.94092908CS
52-2.7289-91.14562458252.9943.4450.237969181.50641532CS
156-17.4349-98.50225988717.733.20.293302202.06872143CS
260-44.7349-99.410888888945149.80.277322822.4748476CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TVGNTevogen Bio Holdings Inc
US$ 1.08
(184.51%)
249.54M
DRUGBright Minds Biosciences Inc
US$ 2.49
(130.58%)
21.5M
INVOINVO BioScience Inc
US$ 1.2246
(86.96%)
56.07M
VERBVerb Technology Company Inc
US$ 12.80
(61.82%)
37.9M
RANIRani Therapeutics Holdings Inc
US$ 3.18
(57.43%)
55.21M
MTEMMolecular Templates Inc
US$ 0.39
(-73.47%)
7.22M
ZPTAZapata Computing Holdings Inc
US$ 0.0768
(-70.57%)
44.51M
VEVVicinity Motor Corporation
US$ 0.0735
(-37.23%)
8.44M
TWGTop Wealth Group Holding Ltd
US$ 4.59
(-35.71%)
11.25M
VCIGVCI Global Ltd
US$ 0.1034
(-23.97%)
14.46M
TVGNTevogen Bio Holdings Inc
US$ 1.08
(184.51%)
249.53M
NVDANVIDIA Corporation
US$ 138.07
(2.43%)
232.41M
GRTSGritstone bio Inc
US$ 0.0544
(6.88%)
172.16M
SOFISoFi Technologies Inc
US$ 10.04
(11.43%)
116.82M
SQQQProShares UltraPro Short QQQ
US$ 6.99
(-2.51%)
113.9M

NVOS Discussion

게시물 보기
Monksdream Monksdream 1 월 전
NVOS new 52 week low
👍️0
Monksdream Monksdream 2 월 전
NVOS new 52 low
👍️0
postal72 postal72 2 월 전
And another one bites the dust. 💩
👍️0
mgland mgland 2 월 전
NVOS delisted 8K AH.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing


https://www.sec.gov/ix?doc=/Archives/edgar/data/1138978/000149315224032650/form8-k.htm


On February 9, 2024, Novo Integrated Sciences, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share (“Common Stock”), for the last 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”) for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Original Notice”). At that time, the Company was provided a compliance period of 180 calendar days from the date of the Original Notice, or until August 7, 2024, to regain compliance with the Minimum Bid Price Requirement, pursuant to Nasdaq Listing Rule 5810(c)(3)(A).



As the Company did not regain compliance with the Minimum Bid Price Requirement by August 7, 2024, and it was determined by the Nasdaq Staff that the Company should not be eligible for another 180 calendar-day extension, the Company received a delisting determination letter on August 9, 2024. Accordingly, the Company intends to timely request a hearing before a Nasdaq Hearing Panel (“Panel”). The hearing request will automatically stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel following the hearing. In that regard, pursuant to the Nasdaq Listing Rules, the Panel has the discretion to grant the Company an additional extension period not to exceed February 5, 2025. However, there can be no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately meet all applicable requirements for continued listing on The Nasdaq Capital Market. The Company intends to provide a plan to regain compliance to the Panel.
👍️0
glenn1919 glenn1919 3 월 전
NVOS..................................https://stockcharts.com/h-sc/ui?s=NVOS&p=W&b=5&g=0&id=p86431144783
👍️0
subslover subslover 3 월 전
Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program
BELLEVUE, Wash.--(BUSINESS WIRE)-- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received notice of the commencement of disbursement for the complete monetization of a Standby Letter of Credit (“SBLC”). The initial disbursement represents the first payment as per the arrangement creating a release of lien resulting in the subsequent final advance to the Company. With this initial disbursement the Company expects final distribution to follow on or before August 2. As previously reported, the Company entered into an application for the monetizing program whereby the Company is projected to receive gross funding proceeds of approximately $78 million under the SBLC monetization program.

Robert Mattacchione, Novo’s CEO and Board Chairman, stated, "The commencement of distribution marks the first payments in the process of full monetization of the SBLC. This step will now lead us to receiving our full expected payout as identified in the transaction documents. We look forward to engaging in our intended initiatives.”

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.

We believe that “decentralizing” healthcare, through the integration of medical technology and interconnectivity, is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and in the future. Specific to non-critical care, ongoing advancements in both medical technology and inter-connectivity are allowing for a shift of the patient/practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions as well as allowing for more cost-effective healthcare distribution.

The Company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers:

First Pillar: Service Networks. Deliver multidisciplinary primary care services through (i) an affiliate network of clinic facilities, (ii) small and micro footprint sized clinic facilities primarily located within the footprint of box-store commercial enterprises, (iii) clinic facilities operated through a franchise relationship with the Company, and (iv) corporate operated clinic facilities.
Second Pillar: Technology. Develop, deploy, and integrate sophisticated interconnected technology, interfacing the patient to the healthcare practitioner thus expanding the reach and availability of the Company’s services, beyond the traditional clinic location, to geographic areas not readily providing advanced, peripheral based healthcare services, including the patient’s home.
Third Pillar: Products. Develop and distribute effective, personalized health and wellness product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier population. The Company’s science-first approach to product innovation further emphasizes our mandate to create and provide over-the-counter preventative and maintenance care solutions.
Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient-first platforms.

For more information concerning Novo Integrated Sciences, please visit www.novointegrated.com.

Twitter, LinkedIn, Facebook, Instagram, YouTube

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," “intend,” "expect," "anticipate," "plan," "potential," "continue," or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in Novo’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown uncertainties and other factors which are, in some cases, beyond Novo’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Novo’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Novo assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240718621664r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20240718621664/en/

Chris David, COO
Novo Integrated Sciences, Inc.
chris.david@novointegrated.com
(888) 512-1195

Source: Novo Integrated Sciences, Inc.

© Copyright Business Wire 2024
Back to News Headlines
Other Financial Information
👍️0
Dr PennyStock Dr PennyStock 3 월 전
$NVOS on fire after-hours. It's trading now at .81, and already made a HOD at .89.
This is what caused the run: https://finance.yahoo.com/news/novo-integrated-sciences-receives-commencement-200500031.htm
👍️0
marianothis marianothis 3 월 전
sounds good to me.
👍️0
Dr PennyStock Dr PennyStock 3 월 전
Strong close. Tomorrow should be a good day.
👍️0
marianothis marianothis 3 월 전
longs are ready.....
👍️0
Dr PennyStock Dr PennyStock 3 월 전
$NVOS made a higher low and a higher high, breaking the resistance at .575. The run to fill the gap at .733 is imminent. Then the run to $5 - $5.38 will initiate.

Weekly chart: https://schrts.co/KWnVIpPq
👍️0
georgie18 georgie18 3 월 전
NVOS...56...Trading sideways...seems to building a base in this range...off the .45 range dip...Open Gap in the .75 range...🥳
👍️0
Sibware Sibware 3 월 전
NVOS:So-close to-push hourly top-bolly at 0.57 b4-effectiveness
👍️0
georgie18 georgie18 3 월 전
NVOS...55s hitting here in the P/M...Off the .45 range dip...🥳
👍️0
georgie18 georgie18 3 월 전
NVOS...5199...Bullish Harami forming here off the .45 range dip...🥳
👍️0
georgie18 georgie18 3 월 전
Thanks Sib...🥳
👍️0
Sibware Sibware 3 월 전
NVOS: Nice grab on this DB. Noteholder should push the top bollies on all counts b4 effectiveness and next PR
Happy to see you healthy like a 10 bagger chart in progress
👍️0
georgie18 georgie18 3 월 전
NVOS...50...Nice bids stacking here...🥳
👍️0
georgie18 georgie18 3 월 전
NVOS...4966 after the .45 range dip...🥳

georgie18

Member Level
Re: georgie18 post# 647672

Tuesday, July 09, 2024 3:30:48 PM

Post#
649307
of 649374
NVOS...45...Hit my target...🥳

georgie18

Member Level
Re: None

Thursday, June 20, 2024 10:59:43 AM

Post#
381519
of 381773
NVOS...78...Watching to see if it fills that .45 range gap...No position...🥳
👍️0
Sibware Sibware 3 월 전
NVOS: Bought back today on this nice DB near 0.45ishes after yesterday's S-1
👍️0
Dr PennyStock Dr PennyStock 3 월 전
How Outstanding Shares Work

As noted above, a company's outstanding shares are those that are held by its shareholders. Any authorized shares that are held by or sold to a corporation’s shareholders, exclusive of treasury stock which is held by the company itself, are known as outstanding shares.

Source: https://www.investopedia.com/terms/o/outstandingshares.asp

The Outstanding shares represent 100 pct of the company at all times.

How can the OS represent 100% of the company if it does not include the treasury stock? So lets say that a company bought back 20% of the issued and outstanding shares, and these shares are now in the treasury. How can the OS represent 100% of the company at all times? In this case represent only 80%.

But suppose that the company bought back 80% of the OS. In this case the OS will represent only 20% of the company, or not?
👍️0
valleybenedetto valleybenedetto 3 월 전
The Outstanding shares represent 100 pct of the company at all times. AS is max they can issue to represent that 100pct hence when the OS goes UP your %ownership in the company goes DOWN..
👍️0
georgie18 georgie18 3 월 전
NVOS...48s clearing here...🥳off the 44 dip...
👍️ 1
Dr PennyStock Dr PennyStock 3 월 전
I have a theory about this sell-off.

This sell-off is very advantageous for the company, because at this price, with the $10M they said they were going to use in the stock buyback, they can buy the entire OS.

$10,000,000 : .50 = 20,000,000

They could avoid the sell-off if today before the market opened they put out a press release saying they were going to start the buyback.

But they didn't, and I think deliberately.

If I am right, this can make a bigger and faster run than I was expecting, even if this sell-off looks ugly.
👍️0
Dr PennyStock Dr PennyStock 3 월 전
An example.

I own a private company and decide to sell 25% of the company on the stock exchange. To make the calculation easier, let's say that 25% of the company is 25 shares.

These shares are issued and sold on the stock exchange. For example, you buy the 25 shares, and by buying the 25 shares (all the shares issued and outstanding), you buy 100% of the company, is that it?

The OS represents 100 pct of the currently issued shares. Yes, but not 100% of the company, right?
👍️0
valleybenedetto valleybenedetto 3 월 전
🫡
👍️0
marianothis marianothis 3 월 전
thank you....
👍️0
valleybenedetto valleybenedetto 3 월 전
No that is absolutely incorrect. The OS represents 100 pct of the currently issued shares. 3.5 million equates to 17.7775 pct dilution to current shareholders.
👍️0
Dr PennyStock Dr PennyStock 3 월 전
I think the AS is more adequate. The AS is 499M, the OS is 19M, so the OS represents 100% of the company?
👍️0
valleybenedetto valleybenedetto 3 월 전
What else do you use ?
👍️0
Dr PennyStock Dr PennyStock 3 월 전
So you use the OS to do that!? Nice
👍️0
valleybenedetto valleybenedetto 3 월 전
17.775 percent to be exact
20m OS
3.5m added do the math.
👍️0
Dr PennyStock Dr PennyStock 3 월 전
More or less 0.7%, not 18%.
👍️0
valleybenedetto valleybenedetto 3 월 전
Thats 18 percent of the company.
👍️0
Sibware Sibware 3 월 전
Last S1 is only for 3.5 million too...
👍️0
marianothis marianothis 3 월 전
Good news, thank you
👍️0
Sibware Sibware 3 월 전
NVOS:S1 out now hence the drop AH.Was due last week according to last 8K but filed today finally

All the data for DD ius always in Edgar filings
https://www.sec.gov/edgar/search/#/q=nvos&dateRange=30d
👍️0
marianothis marianothis 3 월 전
I agree, just wondering on a specific timeframe.
👍️0
valleybenedetto valleybenedetto 3 월 전
Not postponed anymore.
👍️0
Dr PennyStock Dr PennyStock 3 월 전
When was it postponed? I can't find info about that.
👍️0
Sibware Sibware 3 월 전
NVOS:S-1 a/o S-3 filing postponed again but textbook with this CEO. Mid 0.70ishes holding well now
👍️0
Dr PennyStock Dr PennyStock 3 월 전
Don't need. The run will happen, for sure. Just a matter of time.
👍️0
marianothis marianothis 3 월 전
Thanks, I'll keep the fingers crossed
👍️0
Dr PennyStock Dr PennyStock 3 월 전
IMO, the run will start at any moment. Maybe tomorrow or the next day.
👍️0
marianothis marianothis 3 월 전
got a better timeframe ? tia
👍️0
xtyleradx xtyleradx 3 월 전
Took some. Why not
👍️0
Sibware Sibware 3 월 전
error
👍️0
Sibware Sibware 3 월 전
error
👍️0
Sibware Sibware 3 월 전
Textbook S-filing b4 any-news cuz Streeterville and other-friends (GPE Global agreement recently amended for an extension of 1 more year till June 18 2025) always buy b4 any note or other amendment to get the maximum gain$
👍️ 1
Dr PennyStock Dr PennyStock 3 월 전
Good to know. Thanks. Technically I think it may shoot up at any moment, due to the very low volume, higher lows on both charts, daily and weekly, and some indicators showing strong support.
👍️ 1

최근 히스토리

Delayed Upgrade Clock